Immatics (IMTX)

• Market cap: $1.35B
• 1 day: 0%
• 5 days: -1.38%
• 1 month: -5.9%
• 3 months: 72.51%
• 6 months: 63.52%
• Year to date: 35.31%
• 1 year: 35.49%
• 5 years: 3.83%
• 10 years: 4.58%
• Sector: Healthcare
• Industry: Biotechnology

About: Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Employees: 423